source
- European pharma CEOs warn of biotech decline as R&D share drops to 31% and call for faster trials and stronger IP protectionNine leading European pharma board chairs issued an open letter warning that Europe is losing its biotech edge. They note that Europe's share of global pharma R&D fell from 43% in 1990 to 31% toda…
- FDA panel questions effectiveness of Grail's early-cancer detection testFDA's Molecular and Clinical Genetics Panel and agency officials raised concerns about Grail's next-generation sequencing test designed to detect multiple cancers early in adults over 50. The advi…